In the next 3 months we will know if Quest does anything with the urine test. If Quest doesn't make a big deal about it, we will know the test is a loser. So how many shares can Barnhill sell in the next 3 months?? About 250,000 shares at $.20 cents. $50K total, if the price holds up!!
What is he going to do with the other 50 million shares or more that he owns, use it as wall paper?
There are to many other cancer tests that the company can come up with that could turn the stock into $20 a share. Do you think, Richard Curso (COB, CEO and founder of IART) is a dummy, and would he wasting his time and money on a useless cancer breast test. The market for various cancer screening tests is gigantic.
Virtually, every male in the industrialized world will have some degree of prostate cancer if they live to the age of 90. If you catch prostate cancer early, you can fight it in the early stages. If it is the slow moving prostate cancer, you can wait it out because you will probably die first from something else, if it is the fast moving type, you can stop it in various ways before it spreads to other parts of the body. To most males, those choices are important (they will demand them) and there are big $$$ dollars to the company and doctors that will give them that choice.
In 15 years or less they will cut the bad parts of the prostate out and trick the body in to growing health new sections or a completely new prostate (A new acquisition/subsidiary of MIL) and /or they will have treatments (gene changing drugs etc) that will kill the cancer cells. The new screening tests will help researcher find those break through gene treatments.
IMO, within one year of the HDVY quest urine test launch, we will be bought out by a major multi billion dollar company.
So why is he selling these few shares compared to his total holdings, now??? We don't know, but I bet it is not because he things this is the best price he will ever get for his stock.
All flavors of cancer diagnostic tests are going to be hitting the market over the next 4 years. Some of HDVY's cancer tests or future tests are going to be stars of the cancer diagnostic market. They may have 15 minutes of fame, they may have 15 years, it's a gamble, which one and how long. What is not a gamble is that this types of test is the coming trend and it is going to start in earnest, this year.
This is a way out guess. In my opinion, Barnhill want to sell some stock for a dollar or more after Quest launches the urine test. At 750,000 shares per quarter, if the news comes at the end of one quarter and went to $2 a share, it could stay at that level for a few days into the next quarter. At $2 a share, he could sell $1.5 million worth of stock at the end of the first quarter and another $1.5 mil at the beginning of the 2nd quarter. If the stock falls back for what ever reason, to say $.50, he has made $3 million for a small amount of shares over a few days. The 8K reads "up to" 750,000 shares per quarter. When the stock is low price, as it is now, he does not have to sell any stock. At least that is the way I understand it. Many time these stock make a momentum high after the initial spectacular news and then drop back after a few days. They rise again but only after actually results in revenues and net income which proves sustainable over a few years or eventually move to the Nasdaq board. Of course, if they are bought out a year later, this would be meaningless.
PS, IMO, the first prostate test to market will have an edge over any other test and there will be other tests. I'm sure we will be the first to market.
News 
Market Data 
Discover 
AI
